» Articles » PMID: 36776368

Correlation Between the Warburg Effect and Progression of Triple-negative Breast Cancer

Overview
Journal Front Oncol
Specialty Oncology
Date 2023 Feb 13
PMID 36776368
Authors
Affiliations
Soon will be listed here.
Abstract

Triple-negative breast cancer (TNBC) is ineligible for hormonal therapy and Her-2-targeted therapy due to the negative expression of the estrogen receptor, progesterone receptor, and human epidermal growth factor receptor-2. Although targeted therapy and immunotherapy have been shown to attenuate the aggressiveness of TNBC partially, few patients have benefited from them. The conventional treatment for TNBC remains chemotherapy. Chemoresistance, however, impedes therapeutic progress over time, and chemotherapy toxicity increases the burden of cancer on patients. Therefore, introducing more advantageous TNBC treatment options is a necessity. Metabolic reprogramming centered on glucose metabolism is considered a hallmark of tumors. It is described as tumor cells tend to convert glucose to lactate even under normoxic conditions, a phenomenon known as the Warburg effect. Similar to Darwinian evolution, its emergence is attributed to the selective pressures formed by the hypoxic microenvironment of pre-malignant lesions. Of note, the Warburg effect does not disappear with changes in the microenvironment after the formation of malignant tumor phenotypes. Instead, it forms a constitutive expression mediated by mutations or epigenetic modifications, providing a robust selective survival advantage for primary and metastatic lesions. Expanding evidence has demonstrated that the Warburg effect mediates multiple invasive behaviors in TNBC, including proliferation, metastasis, recurrence, immune escape, and multidrug resistance. Moreover, the Warburg effect-targeted therapy has been testified to be feasible in inhibiting TNBC progression. However, not all TNBCs are sensitive to glycolysis inhibitors because TNBC cells flexibly switch their metabolic patterns to cope with different survival pressures, namely metabolic plasticity. Between the Warburg effect-targeted medicines and the actual curative effect, metabolic plasticity creates a divide that must be continuously researched and bridged.

Citing Articles

Exploring Aerobic Energy Metabolism in Breast Cancer: A Mutational Profile of Glycolysis and Oxidative Phosphorylation.

Oliveira R, Cavalcante G, Soares-Souza G Int J Mol Sci. 2024; 25(23).

PMID: 39684297 PMC: 11641591. DOI: 10.3390/ijms252312585.


IGF2BP3 boosts lactate generation to accelerate gastric cancer immune evasion.

Lin K, Lin X, Luo F Apoptosis. 2024; 29(11-12):2147-2160.

PMID: 39397122 DOI: 10.1007/s10495-024-02020-w.


Chemoresistance and the tumor microenvironment: the critical role of cell-cell communication.

Wilczynski B, Dabrowska A, Kulbacka J, Baczynska D Cell Commun Signal. 2024; 22(1):486.

PMID: 39390572 PMC: 11468187. DOI: 10.1186/s12964-024-01857-7.


Bibliometric analysis of phosphoglycerate kinase 1 expression in breast cancer and its distinct upregulation in triple-negative breast cancer.

Chen J, Li J, He R, Huang Z, Chen G, Zou W World J Clin Oncol. 2024; 15(7):867-894.

PMID: 39071464 PMC: 11271732. DOI: 10.5306/wjco.v15.i7.867.


Glucocorticoid receptors orchestrate a convergence of host and cellular stress signals in triple negative breast cancer.

Posani S, Gillis N, Lange C J Steroid Biochem Mol Biol. 2024; 243:106575.

PMID: 38950871 PMC: 11344665. DOI: 10.1016/j.jsbmb.2024.106575.


References
1.
Szczerba B, Castro-Giner F, Vetter M, Krol I, Gkountela S, Landin J . Neutrophils escort circulating tumour cells to enable cell cycle progression. Nature. 2019; 566(7745):553-557. DOI: 10.1038/s41586-019-0915-y. View

2.
Wen J, Yeo S, Wang C, Chen S, Sun S, Haas M . Autophagy inhibition re-sensitizes pulse stimulation-selected paclitaxel-resistant triple negative breast cancer cells to chemotherapy-induced apoptosis. Breast Cancer Res Treat. 2015; 149(3):619-29. PMC: 4764258. DOI: 10.1007/s10549-015-3283-9. View

3.
Santoni M, Romagnoli E, Saladino T, Foghini L, Guarino S, Capponi M . Triple negative breast cancer: Key role of Tumor-Associated Macrophages in regulating the activity of anti-PD-1/PD-L1 agents. Biochim Biophys Acta Rev Cancer. 2017; 1869(1):78-84. DOI: 10.1016/j.bbcan.2017.10.007. View

4.
Peng Y, Chen Z, Chen Y, Li S, Jiang Y, Yang H . ROCK isoforms differentially modulate cancer cell motility by mechanosensing the substrate stiffness. Acta Biomater. 2019; 88:86-101. DOI: 10.1016/j.actbio.2019.02.015. View

5.
Warburg O, Wind F, Negelein E . THE METABOLISM OF TUMORS IN THE BODY. J Gen Physiol. 2009; 8(6):519-30. PMC: 2140820. DOI: 10.1085/jgp.8.6.519. View